Skip to content

Role of dexmedetomidine spary through nasal route on patients comfort and sedation during fiber optic intubation in unstable cervical spine fracture.

Efficacy of atomized intranasal dexmedetomidine on patients comfort and sedation during awake fiber optic intubation in unstable cervical spine fracture -A randomized placebo controlled double blind prospective study.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018027
Enrollment
56
Registered
2019-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Intranasal dexmedetomidine: Intranasal dexmedetomidine(2µg/kg) will be atomized(total volume 2ml eqivalent) through both nostril Control Intervention1: intranasal NS: equivalent volume

Sponsors

BANGUR INSTITUE OF NEUROSCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with anticipated difficult airway 1.Unstable cervical spine posted for -elective cervical fixation

Exclusion criteria

Exclusion criteria: 1.Patient having sensitivity to local anesthesia 2.ASA-III &IV 3.Higher degree of A-V Block 4.Obstructive sleep apnea 5.Morbid obesity 6.Patient on ACE inhibitor, alpha antagonist, TCA

Design outcomes

Primary

MeasureTime frame
a)To assess the patientâ??s comfort and sedation through OAA/S score b) comfort score Timepoint: OAA/S score at 10,20 ,30,35,40 min after study drug administration, b) Patientâ??s comfort by 5 points fiberoptic intubation comfort score during AFOI,

Secondary

MeasureTime frame
1) haemodynamic alternation, 2) ease of intubation, 3) postoperative recallTimepoint: , Ease of intubation by operator through intubation score during AFOI, Hemodynamic parameters at different time intervals before, during and after AFOI. Postoperative recall 24 hr after operation by 5 point awareness scale.

Countries

India

Contacts

Public ContactPROFESSOR DR AMITA ACHARJEE PAHARI

BANGUR INSTITUTE OF NEURO SCIENCES

dr.amitaacharya@yahoo.com9831650768

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026